PDS Biotechnology Corporation (PDSB) has provided an update.
PDS Biotechnology Corporation has appointed Stephan F. Toutain as their new Chief Operations Officer, starting May 1, 2024. Bringing over three decades of pharmaceutical industry experience, Toutain has held significant roles at companies like Anavex Life Sciences and Interleukin Genetics. His compensation includes a $450,000 annual salary with potential for a 40% bonus, stock options, and severance benefits under certain conditions. The company announced his appointment in a press release on May 2, 2024.
For an in-depth examination of PDSB stock, go to TipRanks’ Stock Analysis page.
